Srikanth Ambati

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

Ayuko Hoshino, Han Sang Kim, Linda Bojmar et al. · Cell · 2020 · 1.2K citations · Full text

Medicine, Cancer Biology, Oncology +12

Odronextamab (REGN1979), a Human CD20 x CD3 Bispecific Antibody, Induces Durable, Complete Responses in Patients with Highly Refractory B-Cell Non-Hodgkin Lymphoma, Including Patients Refractory to CAR T Therapy

Rajat Bannerji, John N. Allan, Jon Arnason et al. · Blood · 2020 · 108 citations

Life Sciences, Immunology, Oncology +17

Recapitulating the Size and Cargo of Tumor Exosomes in a Tissue-Engineered Model

Aránzazu Villasante, Alessandro Marturano-Kruik, Srikanth Ambati et al. · Theranostics · 2016 · 94 citations · Full text

Medicine, Molecular Biology, Oncology +17

Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma

Tae Min Kim, Michał Taszner, Silvana Novelli et al. · Annals of Oncology · 2024 · 76 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Pre‐clinical efficacy of PU‐H71, a novel HSP90 inhibitor, alone and in combination with bortezomib in Ewing sarcoma

Srikanth Ambati, Eloisi Caldas Lopes, Kohji Kosugi et al. · Molecular Oncology · 2013 · 64 citations · Full text

Medicine, Oncology, Pharmacology +17